Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques E Rossouw

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Thrombosis Research|January 8, 2017
Venous thromboembolism incidence, recurrence, and mortality based on Women's Health Initiative data and Medicare claimsDale R Burwen, Chunyuan Wu, Dominic Cirillo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
Variation in the FGFR2 gene and the effect of a low-fat dietary pattern on invasive breast cancerRoss L Prentice, Ying Huang, David A Hinds, et al.
Genome Medicine|July 17, 2012
Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke riskYing Huang, Dennis G Ballinger, Renee Stokowski, et al.
JAMA|April 5, 2007
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopauseJacques E Rossouw, Ross L Prentice, JoAnn E Manson, et al.
Circulation|March 9, 2012
Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health InitiativeNancy R Cook, Nina P Paynter, Charles B Eaton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2009
Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancerRoss L Prentice, Ying Huang, David A Hinds, et al.
JAMA|August 23, 2002
Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational studyAruna D Pradhan, JoAnn E Manson, Jacques E Rossouw, et al.
Circulation|February 19, 2004
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002 : Section 4: lessons from hormone replacement trialsDavid D Waters, David Gordon, Jacques E Rossouw, et al.
Journal of the American College of Cardiology|May 8, 2010
Multimarker prediction of coronary heart disease risk: the Women's Health InitiativeHyeon Chang Kim, Philip Greenland, Jacques E Rossouw, et al.
Annals of Internal Medicine|May 7, 2014
Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling studyJoshua A Roth, Ruth Etzioni, Teresa M Waters, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Thrombosis Research|January 8, 2017
Venous thromboembolism incidence, recurrence, and mortality based on Women's Health Initiative data and Medicare claimsDale R Burwen, Chunyuan Wu, Dominic Cirillo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
Variation in the FGFR2 gene and the effect of a low-fat dietary pattern on invasive breast cancerRoss L Prentice, Ying Huang, David A Hinds, et al.
Genome Medicine|July 17, 2012
Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke riskYing Huang, Dennis G Ballinger, Renee Stokowski, et al.
JAMA|April 5, 2007
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopauseJacques E Rossouw, Ross L Prentice, JoAnn E Manson, et al.
Circulation|March 9, 2012
Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health InitiativeNancy R Cook, Nina P Paynter, Charles B Eaton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2009
Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancerRoss L Prentice, Ying Huang, David A Hinds, et al.
JAMA|August 23, 2002
Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational studyAruna D Pradhan, JoAnn E Manson, Jacques E Rossouw, et al.
Circulation|February 19, 2004
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002 : Section 4: lessons from hormone replacement trialsDavid D Waters, David Gordon, Jacques E Rossouw, et al.
Journal of the American College of Cardiology|May 8, 2010
Multimarker prediction of coronary heart disease risk: the Women's Health InitiativeHyeon Chang Kim, Philip Greenland, Jacques E Rossouw, et al.
Annals of Internal Medicine|May 7, 2014
Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling studyJoshua A Roth, Ruth Etzioni, Teresa M Waters, et al.
Pageof 10